Global Nocturia Supply, Demand and Key Producers, 2026-2032
The global Nocturia market size is expected to reach $ 4358 million by 2032, rising at a market growth of 4.9% CAGR during the forecast period (2026-2032).
Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.
The global nocturia market, focused on the treatment of nighttime urination, is growing due to an increasing aging population, rising awareness of urinary disorders, and advancements in treatment options. Below are some key trends driving the market:
1. Growing Aging Population
Primary Driver: Nocturia is more prevalent among the elderly, and with a rapidly aging global population, the demand for nocturia treatments is rising. Regions with older populations, such as Europe, North America, and Japan, are seeing increased incidence rates.
Impact: The increase in elderly individuals with nocturia-related issues is expected to drive the demand for pharmaceutical treatments and non-pharmaceutical interventions.
2. Advancements in Treatment Options
Medications: A range of medications, including anticholinergics, desmopressin, and beta-3 adrenergic receptor agonists, are commonly used to treat nocturia. New drug formulations are being developed to reduce side effects and improve efficacy.
Emerging Therapies: Research into gene therapies and targeted molecular therapies is advancing. Additionally, the combination of medications for better symptom control is being explored.
Non-Pharmacological Treatments: Beyond drugs, lifestyle interventions, such as fluid management, bladder training, and devices like bedwetting alarms, are gaining attention as complementary treatments.
3. Increasing Awareness and Diagnosis
Education: Public health campaigns and awareness programs about nocturia are encouraging individuals to seek medical help. Increased awareness is expected to drive the market as more people seek treatment for the condition.
Early Diagnosis: Enhanced diagnostic tools, including better urodynamic testing and digital health platforms for symptom tracking, are improving early detection and management of nocturia.
4. Regional Growth
North America: The U.S. holds the largest market share due to its advanced healthcare infrastructure, higher awareness, and the presence of major pharmaceutical companies. Increasing cases of nocturia among older adults are a significant market driver.
Europe: Aging populations, particularly in Western Europe, are contributing to the increased demand for nocturia treatments. The market in this region benefits from well-established healthcare systems.
Asia-Pacific: The growing healthcare infrastructure in countries like China, Japan, and India is expected to boost market growth. Rising healthcare expenditure and increasing elderly populations in these regions are key factors.
Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.
This report studies the global Nocturia demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nocturia, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nocturia that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nocturia total market, 2021-2032, (USD Million)
Global Nocturia total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Nocturia total market, key domestic companies, and share, (USD Million)
Global Nocturia revenue by player, revenue and market share 2021-2026, (USD Million)
Global Nocturia total market by Type, CAGR, 2021-2032, (USD Million)
Global Nocturia total market by Sale Channels, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Nocturia market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Sanofi, Pfizer, Abbott, Teva, Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Nocturia market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Sale Channels. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Nocturia Market, By Region:
1. How big is the global Nocturia market?
2. What is the demand of the global Nocturia market?
3. What is the year over year growth of the global Nocturia market?
4. What is the total value of the global Nocturia market?
5. Who are the Major Players in the global Nocturia market?
6. What are the growth factors driving the market demand?
Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.
The global nocturia market, focused on the treatment of nighttime urination, is growing due to an increasing aging population, rising awareness of urinary disorders, and advancements in treatment options. Below are some key trends driving the market:
1. Growing Aging Population
Primary Driver: Nocturia is more prevalent among the elderly, and with a rapidly aging global population, the demand for nocturia treatments is rising. Regions with older populations, such as Europe, North America, and Japan, are seeing increased incidence rates.
Impact: The increase in elderly individuals with nocturia-related issues is expected to drive the demand for pharmaceutical treatments and non-pharmaceutical interventions.
2. Advancements in Treatment Options
Medications: A range of medications, including anticholinergics, desmopressin, and beta-3 adrenergic receptor agonists, are commonly used to treat nocturia. New drug formulations are being developed to reduce side effects and improve efficacy.
Emerging Therapies: Research into gene therapies and targeted molecular therapies is advancing. Additionally, the combination of medications for better symptom control is being explored.
Non-Pharmacological Treatments: Beyond drugs, lifestyle interventions, such as fluid management, bladder training, and devices like bedwetting alarms, are gaining attention as complementary treatments.
3. Increasing Awareness and Diagnosis
Education: Public health campaigns and awareness programs about nocturia are encouraging individuals to seek medical help. Increased awareness is expected to drive the market as more people seek treatment for the condition.
Early Diagnosis: Enhanced diagnostic tools, including better urodynamic testing and digital health platforms for symptom tracking, are improving early detection and management of nocturia.
4. Regional Growth
North America: The U.S. holds the largest market share due to its advanced healthcare infrastructure, higher awareness, and the presence of major pharmaceutical companies. Increasing cases of nocturia among older adults are a significant market driver.
Europe: Aging populations, particularly in Western Europe, are contributing to the increased demand for nocturia treatments. The market in this region benefits from well-established healthcare systems.
Asia-Pacific: The growing healthcare infrastructure in countries like China, Japan, and India is expected to boost market growth. Rising healthcare expenditure and increasing elderly populations in these regions are key factors.
Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.
This report studies the global Nocturia demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nocturia, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nocturia that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nocturia total market, 2021-2032, (USD Million)
Global Nocturia total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Nocturia total market, key domestic companies, and share, (USD Million)
Global Nocturia revenue by player, revenue and market share 2021-2026, (USD Million)
Global Nocturia total market by Type, CAGR, 2021-2032, (USD Million)
Global Nocturia total market by Sale Channels, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Nocturia market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Sanofi, Pfizer, Abbott, Teva, Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Nocturia market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Sale Channels. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Nocturia Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Desmopressin
- Anticholinergic Drugs
- Alpha Blockers
- Diuretics
- Others
- For Nocturnal Polyuria
- For Overactive Bladder
- For Prostate-related Nocturia
- Others
- Hormonal Drugs
- Urological Functional Agents
- BPH Symptom Therapies
- Diuretics
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Astellas Pharma
- Allergan
- Ferring Pharmaceuticals
- Eli Lilly
- GlaxoSmithKline
- Sanofi
- Pfizer
- Abbott
- Teva
- Mylan
- Novartis
- Johnson & Johnson
- Merck
- Astra Zeneca
- Bristol-Myers Squibb
- Hainan Zhonghe Pharmaceutical
- Fosun Pharma
- Hybio Pharmaceutical
- Rechon Life Science AB
- Zhejiang Conba Pharmaceutical
- Chengdu Leer Pharmaceutical
- Nanjing Xingyin Pharmaceutical Group
- Sun Pharmaceutical Industries Ltd.
- APOTEX INC
- Sagent Pharmaceuticals
1. How big is the global Nocturia market?
2. What is the demand of the global Nocturia market?
3. What is the year over year growth of the global Nocturia market?
4. What is the total value of the global Nocturia market?
5. Who are the Major Players in the global Nocturia market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Nocturia Introduction
1.2 World Nocturia Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Nocturia Total Market by Region (by Headquarter Location)
1.3.1 World Nocturia Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Nocturia Revenue (2021-2032)
1.3.3 China Based Company Nocturia Revenue (2021-2032)
1.3.4 Europe Based Company Nocturia Revenue (2021-2032)
1.3.5 Japan Based Company Nocturia Revenue (2021-2032)
1.3.6 South Korea Based Company Nocturia Revenue (2021-2032)
1.3.7 ASEAN Based Company Nocturia Revenue (2021-2032)
1.3.8 India Based Company Nocturia Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nocturia Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Nocturia Consumption Value (2021-2032)
2.2 World Nocturia Consumption Value by Region
2.2.1 World Nocturia Consumption Value by Region (2021-2026)
2.2.2 World Nocturia Consumption Value Forecast by Region (2027-2032)
2.3 United States Nocturia Consumption Value (2021-2032)
2.4 China Nocturia Consumption Value (2021-2032)
2.5 Europe Nocturia Consumption Value (2021-2032)
2.6 Japan Nocturia Consumption Value (2021-2032)
2.7 South Korea Nocturia Consumption Value (2021-2032)
2.8 ASEAN Nocturia Consumption Value (2021-2032)
2.9 India Nocturia Consumption Value (2021-2032)
3 WORLD NOCTURIA COMPANIES COMPETITIVE ANALYSIS
3.1 World Nocturia Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Nocturia Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Nocturia in 2025
3.2.3 Global Concentration Ratios (CR8) for Nocturia in 2025
3.3 Nocturia Company Evaluation Quadrant
3.4 Nocturia Market: Overall Company Footprint Analysis
3.4.1 Nocturia Market: Region Footprint
3.4.2 Nocturia Market: Company Product Type Footprint
3.4.3 Nocturia Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Nocturia Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Nocturia Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Nocturia Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Nocturia Consumption Value Comparison
4.2.1 United States VS China: Nocturia Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Nocturia Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Nocturia Companies and Market Share, 2021-2026
4.3.1 United States Based Nocturia Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Nocturia Revenue, (2021-2026)
4.4 China Based Companies Nocturia Revenue and Market Share, 2021-2026
4.4.1 China Based Nocturia Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Nocturia Revenue, (2021-2026)
4.5 Rest of World Based Nocturia Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Nocturia Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Nocturia Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Nocturia Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Desmopressin
5.2.2 Anticholinergic Drugs
5.2.3 Alpha Blockers
5.2.4 Diuretics
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Nocturia Market Size by Type (2021-2026)
5.3.2 World Nocturia Market Size by Type (2027-2032)
5.3.3 World Nocturia Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY UNDERLYING CAUSE
6.1 World Nocturia Market Size Overview by Underlying Cause: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Underlying Cause
6.2.1 For Nocturnal Polyuria
6.2.2 For Overactive Bladder
6.2.3 For Prostate-related Nocturia
6.2.4 Others
6.3 Market Segment by Underlying Cause
6.3.1 World Nocturia Market Size by Underlying Cause (2021-2026)
6.3.2 World Nocturia Market Size by Underlying Cause (2027-2032)
6.3.3 World Nocturia Market Size Market Share by Underlying Cause (2027-2032)
7 MARKET ANALYSIS BY DRUG CATEGORY
7.1 World Nocturia Market Size Overview by Drug Category: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Drug Category
7.2.1 Hormonal Drugs
7.2.2 Urological Functional Agents
7.2.3 BPH Symptom Therapies
7.2.4 Diuretics
7.2.5 Others
7.3 Market Segment by Drug Category
7.3.1 World Nocturia Market Size by Drug Category (2021-2026)
7.3.2 World Nocturia Market Size by Drug Category (2027-2032)
7.3.3 World Nocturia Market Size Market Share by Drug Category (2027-2032)
8 MARKET ANALYSIS BY SALE CHANNELS
8.1 World Nocturia Market Size Overview by Sale Channels: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Sale Channels
8.2.1 Hospital Pharmacies
8.2.2 Retail Pharmacies
8.2.3 Online Pharmacies
8.3 Market Segment by Sale Channels
8.3.1 World Nocturia Market Size by Sale Channels (2021-2026)
8.3.2 World Nocturia Market Size by Sale Channels (2027-2032)
8.3.3 World Nocturia Market Size Market Share by Sale Channels (2021-2032)
9 COMPANY PROFILES
9.1 Astellas Pharma
9.1.1 Astellas Pharma Details
9.1.2 Astellas Pharma Major Business
9.1.3 Astellas Pharma Nocturia Product and Services
9.1.4 Astellas Pharma Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Astellas Pharma Recent Developments/Updates
9.1.6 Astellas Pharma Competitive Strengths & Weaknesses
9.2 Allergan
9.2.1 Allergan Details
9.2.2 Allergan Major Business
9.2.3 Allergan Nocturia Product and Services
9.2.4 Allergan Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Allergan Recent Developments/Updates
9.2.6 Allergan Competitive Strengths & Weaknesses
9.3 Ferring Pharmaceuticals
9.3.1 Ferring Pharmaceuticals Details
9.3.2 Ferring Pharmaceuticals Major Business
9.3.3 Ferring Pharmaceuticals Nocturia Product and Services
9.3.4 Ferring Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Ferring Pharmaceuticals Recent Developments/Updates
9.3.6 Ferring Pharmaceuticals Competitive Strengths & Weaknesses
9.4 Eli Lilly
9.4.1 Eli Lilly Details
9.4.2 Eli Lilly Major Business
9.4.3 Eli Lilly Nocturia Product and Services
9.4.4 Eli Lilly Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Eli Lilly Recent Developments/Updates
9.4.6 Eli Lilly Competitive Strengths & Weaknesses
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Details
9.5.2 GlaxoSmithKline Major Business
9.5.3 GlaxoSmithKline Nocturia Product and Services
9.5.4 GlaxoSmithKline Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 GlaxoSmithKline Recent Developments/Updates
9.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses
9.6 Sanofi
9.6.1 Sanofi Details
9.6.2 Sanofi Major Business
9.6.3 Sanofi Nocturia Product and Services
9.6.4 Sanofi Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Sanofi Recent Developments/Updates
9.6.6 Sanofi Competitive Strengths & Weaknesses
9.7 Pfizer
9.7.1 Pfizer Details
9.7.2 Pfizer Major Business
9.7.3 Pfizer Nocturia Product and Services
9.7.4 Pfizer Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Pfizer Recent Developments/Updates
9.7.6 Pfizer Competitive Strengths & Weaknesses
9.8 Abbott
9.8.1 Abbott Details
9.8.2 Abbott Major Business
9.8.3 Abbott Nocturia Product and Services
9.8.4 Abbott Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Abbott Recent Developments/Updates
9.8.6 Abbott Competitive Strengths & Weaknesses
9.9 Teva
9.9.1 Teva Details
9.9.2 Teva Major Business
9.9.3 Teva Nocturia Product and Services
9.9.4 Teva Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Teva Recent Developments/Updates
9.9.6 Teva Competitive Strengths & Weaknesses
9.10 Mylan
9.10.1 Mylan Details
9.10.2 Mylan Major Business
9.10.3 Mylan Nocturia Product and Services
9.10.4 Mylan Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Mylan Recent Developments/Updates
9.10.6 Mylan Competitive Strengths & Weaknesses
9.11 Novartis
9.11.1 Novartis Details
9.11.2 Novartis Major Business
9.11.3 Novartis Nocturia Product and Services
9.11.4 Novartis Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Novartis Recent Developments/Updates
9.11.6 Novartis Competitive Strengths & Weaknesses
9.12 Johnson & Johnson
9.12.1 Johnson & Johnson Details
9.12.2 Johnson & Johnson Major Business
9.12.3 Johnson & Johnson Nocturia Product and Services
9.12.4 Johnson & Johnson Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Johnson & Johnson Recent Developments/Updates
9.12.6 Johnson & Johnson Competitive Strengths & Weaknesses
9.13 Merck
9.13.1 Merck Details
9.13.2 Merck Major Business
9.13.3 Merck Nocturia Product and Services
9.13.4 Merck Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Merck Recent Developments/Updates
9.13.6 Merck Competitive Strengths & Weaknesses
9.14 Astra Zeneca
9.14.1 Astra Zeneca Details
9.14.2 Astra Zeneca Major Business
9.14.3 Astra Zeneca Nocturia Product and Services
9.14.4 Astra Zeneca Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Astra Zeneca Recent Developments/Updates
9.14.6 Astra Zeneca Competitive Strengths & Weaknesses
9.15 Bristol-Myers Squibb
9.15.1 Bristol-Myers Squibb Details
9.15.2 Bristol-Myers Squibb Major Business
9.15.3 Bristol-Myers Squibb Nocturia Product and Services
9.15.4 Bristol-Myers Squibb Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Bristol-Myers Squibb Recent Developments/Updates
9.15.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
9.16 Hainan Zhonghe Pharmaceutical
9.16.1 Hainan Zhonghe Pharmaceutical Details
9.16.2 Hainan Zhonghe Pharmaceutical Major Business
9.16.3 Hainan Zhonghe Pharmaceutical Nocturia Product and Services
9.16.4 Hainan Zhonghe Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Hainan Zhonghe Pharmaceutical Recent Developments/Updates
9.16.6 Hainan Zhonghe Pharmaceutical Competitive Strengths & Weaknesses
9.17 Fosun Pharma
9.17.1 Fosun Pharma Details
9.17.2 Fosun Pharma Major Business
9.17.3 Fosun Pharma Nocturia Product and Services
9.17.4 Fosun Pharma Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Fosun Pharma Recent Developments/Updates
9.17.6 Fosun Pharma Competitive Strengths & Weaknesses
9.18 Hybio Pharmaceutical
9.18.1 Hybio Pharmaceutical Details
9.18.2 Hybio Pharmaceutical Major Business
9.18.3 Hybio Pharmaceutical Nocturia Product and Services
9.18.4 Hybio Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Hybio Pharmaceutical Recent Developments/Updates
9.18.6 Hybio Pharmaceutical Competitive Strengths & Weaknesses
9.19 Rechon Life Science AB
9.19.1 Rechon Life Science AB Details
9.19.2 Rechon Life Science AB Major Business
9.19.3 Rechon Life Science AB Nocturia Product and Services
9.19.4 Rechon Life Science AB Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Rechon Life Science AB Recent Developments/Updates
9.19.6 Rechon Life Science AB Competitive Strengths & Weaknesses
9.20 Zhejiang Conba Pharmaceutical
9.20.1 Zhejiang Conba Pharmaceutical Details
9.20.2 Zhejiang Conba Pharmaceutical Major Business
9.20.3 Zhejiang Conba Pharmaceutical Nocturia Product and Services
9.20.4 Zhejiang Conba Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Zhejiang Conba Pharmaceutical Recent Developments/Updates
9.20.6 Zhejiang Conba Pharmaceutical Competitive Strengths & Weaknesses
9.21 Chengdu Leer Pharmaceutical
9.21.1 Chengdu Leer Pharmaceutical Details
9.21.2 Chengdu Leer Pharmaceutical Major Business
9.21.3 Chengdu Leer Pharmaceutical Nocturia Product and Services
9.21.4 Chengdu Leer Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Chengdu Leer Pharmaceutical Recent Developments/Updates
9.21.6 Chengdu Leer Pharmaceutical Competitive Strengths & Weaknesses
9.22 Nanjing Xingyin Pharmaceutical Group
9.22.1 Nanjing Xingyin Pharmaceutical Group Details
9.22.2 Nanjing Xingyin Pharmaceutical Group Major Business
9.22.3 Nanjing Xingyin Pharmaceutical Group Nocturia Product and Services
9.22.4 Nanjing Xingyin Pharmaceutical Group Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Nanjing Xingyin Pharmaceutical Group Recent Developments/Updates
9.22.6 Nanjing Xingyin Pharmaceutical Group Competitive Strengths & Weaknesses
9.23 Sun Pharmaceutical Industries Ltd.
9.23.1 Sun Pharmaceutical Industries Ltd. Details
9.23.2 Sun Pharmaceutical Industries Ltd. Major Business
9.23.3 Sun Pharmaceutical Industries Ltd. Nocturia Product and Services
9.23.4 Sun Pharmaceutical Industries Ltd. Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
9.23.6 Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
9.24 APOTEX INC
9.24.1 APOTEX INC Details
9.24.2 APOTEX INC Major Business
9.24.3 APOTEX INC Nocturia Product and Services
9.24.4 APOTEX INC Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 APOTEX INC Recent Developments/Updates
9.24.6 APOTEX INC Competitive Strengths & Weaknesses
9.25 Sagent Pharmaceuticals
9.25.1 Sagent Pharmaceuticals Details
9.25.2 Sagent Pharmaceuticals Major Business
9.25.3 Sagent Pharmaceuticals Nocturia Product and Services
9.25.4 Sagent Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Sagent Pharmaceuticals Recent Developments/Updates
9.25.6 Sagent Pharmaceuticals Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Nocturia Industry Chain
10.2 Nocturia Upstream Analysis
10.3 Nocturia Midstream Analysis
10.4 Nocturia Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Nocturia Introduction
1.2 World Nocturia Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Nocturia Total Market by Region (by Headquarter Location)
1.3.1 World Nocturia Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Nocturia Revenue (2021-2032)
1.3.3 China Based Company Nocturia Revenue (2021-2032)
1.3.4 Europe Based Company Nocturia Revenue (2021-2032)
1.3.5 Japan Based Company Nocturia Revenue (2021-2032)
1.3.6 South Korea Based Company Nocturia Revenue (2021-2032)
1.3.7 ASEAN Based Company Nocturia Revenue (2021-2032)
1.3.8 India Based Company Nocturia Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nocturia Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Nocturia Consumption Value (2021-2032)
2.2 World Nocturia Consumption Value by Region
2.2.1 World Nocturia Consumption Value by Region (2021-2026)
2.2.2 World Nocturia Consumption Value Forecast by Region (2027-2032)
2.3 United States Nocturia Consumption Value (2021-2032)
2.4 China Nocturia Consumption Value (2021-2032)
2.5 Europe Nocturia Consumption Value (2021-2032)
2.6 Japan Nocturia Consumption Value (2021-2032)
2.7 South Korea Nocturia Consumption Value (2021-2032)
2.8 ASEAN Nocturia Consumption Value (2021-2032)
2.9 India Nocturia Consumption Value (2021-2032)
3 WORLD NOCTURIA COMPANIES COMPETITIVE ANALYSIS
3.1 World Nocturia Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Nocturia Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Nocturia in 2025
3.2.3 Global Concentration Ratios (CR8) for Nocturia in 2025
3.3 Nocturia Company Evaluation Quadrant
3.4 Nocturia Market: Overall Company Footprint Analysis
3.4.1 Nocturia Market: Region Footprint
3.4.2 Nocturia Market: Company Product Type Footprint
3.4.3 Nocturia Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Nocturia Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Nocturia Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Nocturia Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Nocturia Consumption Value Comparison
4.2.1 United States VS China: Nocturia Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Nocturia Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Nocturia Companies and Market Share, 2021-2026
4.3.1 United States Based Nocturia Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Nocturia Revenue, (2021-2026)
4.4 China Based Companies Nocturia Revenue and Market Share, 2021-2026
4.4.1 China Based Nocturia Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Nocturia Revenue, (2021-2026)
4.5 Rest of World Based Nocturia Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Nocturia Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Nocturia Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Nocturia Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Desmopressin
5.2.2 Anticholinergic Drugs
5.2.3 Alpha Blockers
5.2.4 Diuretics
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Nocturia Market Size by Type (2021-2026)
5.3.2 World Nocturia Market Size by Type (2027-2032)
5.3.3 World Nocturia Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY UNDERLYING CAUSE
6.1 World Nocturia Market Size Overview by Underlying Cause: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Underlying Cause
6.2.1 For Nocturnal Polyuria
6.2.2 For Overactive Bladder
6.2.3 For Prostate-related Nocturia
6.2.4 Others
6.3 Market Segment by Underlying Cause
6.3.1 World Nocturia Market Size by Underlying Cause (2021-2026)
6.3.2 World Nocturia Market Size by Underlying Cause (2027-2032)
6.3.3 World Nocturia Market Size Market Share by Underlying Cause (2027-2032)
7 MARKET ANALYSIS BY DRUG CATEGORY
7.1 World Nocturia Market Size Overview by Drug Category: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Drug Category
7.2.1 Hormonal Drugs
7.2.2 Urological Functional Agents
7.2.3 BPH Symptom Therapies
7.2.4 Diuretics
7.2.5 Others
7.3 Market Segment by Drug Category
7.3.1 World Nocturia Market Size by Drug Category (2021-2026)
7.3.2 World Nocturia Market Size by Drug Category (2027-2032)
7.3.3 World Nocturia Market Size Market Share by Drug Category (2027-2032)
8 MARKET ANALYSIS BY SALE CHANNELS
8.1 World Nocturia Market Size Overview by Sale Channels: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Sale Channels
8.2.1 Hospital Pharmacies
8.2.2 Retail Pharmacies
8.2.3 Online Pharmacies
8.3 Market Segment by Sale Channels
8.3.1 World Nocturia Market Size by Sale Channels (2021-2026)
8.3.2 World Nocturia Market Size by Sale Channels (2027-2032)
8.3.3 World Nocturia Market Size Market Share by Sale Channels (2021-2032)
9 COMPANY PROFILES
9.1 Astellas Pharma
9.1.1 Astellas Pharma Details
9.1.2 Astellas Pharma Major Business
9.1.3 Astellas Pharma Nocturia Product and Services
9.1.4 Astellas Pharma Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Astellas Pharma Recent Developments/Updates
9.1.6 Astellas Pharma Competitive Strengths & Weaknesses
9.2 Allergan
9.2.1 Allergan Details
9.2.2 Allergan Major Business
9.2.3 Allergan Nocturia Product and Services
9.2.4 Allergan Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Allergan Recent Developments/Updates
9.2.6 Allergan Competitive Strengths & Weaknesses
9.3 Ferring Pharmaceuticals
9.3.1 Ferring Pharmaceuticals Details
9.3.2 Ferring Pharmaceuticals Major Business
9.3.3 Ferring Pharmaceuticals Nocturia Product and Services
9.3.4 Ferring Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Ferring Pharmaceuticals Recent Developments/Updates
9.3.6 Ferring Pharmaceuticals Competitive Strengths & Weaknesses
9.4 Eli Lilly
9.4.1 Eli Lilly Details
9.4.2 Eli Lilly Major Business
9.4.3 Eli Lilly Nocturia Product and Services
9.4.4 Eli Lilly Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Eli Lilly Recent Developments/Updates
9.4.6 Eli Lilly Competitive Strengths & Weaknesses
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Details
9.5.2 GlaxoSmithKline Major Business
9.5.3 GlaxoSmithKline Nocturia Product and Services
9.5.4 GlaxoSmithKline Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 GlaxoSmithKline Recent Developments/Updates
9.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses
9.6 Sanofi
9.6.1 Sanofi Details
9.6.2 Sanofi Major Business
9.6.3 Sanofi Nocturia Product and Services
9.6.4 Sanofi Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Sanofi Recent Developments/Updates
9.6.6 Sanofi Competitive Strengths & Weaknesses
9.7 Pfizer
9.7.1 Pfizer Details
9.7.2 Pfizer Major Business
9.7.3 Pfizer Nocturia Product and Services
9.7.4 Pfizer Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Pfizer Recent Developments/Updates
9.7.6 Pfizer Competitive Strengths & Weaknesses
9.8 Abbott
9.8.1 Abbott Details
9.8.2 Abbott Major Business
9.8.3 Abbott Nocturia Product and Services
9.8.4 Abbott Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Abbott Recent Developments/Updates
9.8.6 Abbott Competitive Strengths & Weaknesses
9.9 Teva
9.9.1 Teva Details
9.9.2 Teva Major Business
9.9.3 Teva Nocturia Product and Services
9.9.4 Teva Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Teva Recent Developments/Updates
9.9.6 Teva Competitive Strengths & Weaknesses
9.10 Mylan
9.10.1 Mylan Details
9.10.2 Mylan Major Business
9.10.3 Mylan Nocturia Product and Services
9.10.4 Mylan Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Mylan Recent Developments/Updates
9.10.6 Mylan Competitive Strengths & Weaknesses
9.11 Novartis
9.11.1 Novartis Details
9.11.2 Novartis Major Business
9.11.3 Novartis Nocturia Product and Services
9.11.4 Novartis Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Novartis Recent Developments/Updates
9.11.6 Novartis Competitive Strengths & Weaknesses
9.12 Johnson & Johnson
9.12.1 Johnson & Johnson Details
9.12.2 Johnson & Johnson Major Business
9.12.3 Johnson & Johnson Nocturia Product and Services
9.12.4 Johnson & Johnson Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Johnson & Johnson Recent Developments/Updates
9.12.6 Johnson & Johnson Competitive Strengths & Weaknesses
9.13 Merck
9.13.1 Merck Details
9.13.2 Merck Major Business
9.13.3 Merck Nocturia Product and Services
9.13.4 Merck Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Merck Recent Developments/Updates
9.13.6 Merck Competitive Strengths & Weaknesses
9.14 Astra Zeneca
9.14.1 Astra Zeneca Details
9.14.2 Astra Zeneca Major Business
9.14.3 Astra Zeneca Nocturia Product and Services
9.14.4 Astra Zeneca Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Astra Zeneca Recent Developments/Updates
9.14.6 Astra Zeneca Competitive Strengths & Weaknesses
9.15 Bristol-Myers Squibb
9.15.1 Bristol-Myers Squibb Details
9.15.2 Bristol-Myers Squibb Major Business
9.15.3 Bristol-Myers Squibb Nocturia Product and Services
9.15.4 Bristol-Myers Squibb Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Bristol-Myers Squibb Recent Developments/Updates
9.15.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
9.16 Hainan Zhonghe Pharmaceutical
9.16.1 Hainan Zhonghe Pharmaceutical Details
9.16.2 Hainan Zhonghe Pharmaceutical Major Business
9.16.3 Hainan Zhonghe Pharmaceutical Nocturia Product and Services
9.16.4 Hainan Zhonghe Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Hainan Zhonghe Pharmaceutical Recent Developments/Updates
9.16.6 Hainan Zhonghe Pharmaceutical Competitive Strengths & Weaknesses
9.17 Fosun Pharma
9.17.1 Fosun Pharma Details
9.17.2 Fosun Pharma Major Business
9.17.3 Fosun Pharma Nocturia Product and Services
9.17.4 Fosun Pharma Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Fosun Pharma Recent Developments/Updates
9.17.6 Fosun Pharma Competitive Strengths & Weaknesses
9.18 Hybio Pharmaceutical
9.18.1 Hybio Pharmaceutical Details
9.18.2 Hybio Pharmaceutical Major Business
9.18.3 Hybio Pharmaceutical Nocturia Product and Services
9.18.4 Hybio Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Hybio Pharmaceutical Recent Developments/Updates
9.18.6 Hybio Pharmaceutical Competitive Strengths & Weaknesses
9.19 Rechon Life Science AB
9.19.1 Rechon Life Science AB Details
9.19.2 Rechon Life Science AB Major Business
9.19.3 Rechon Life Science AB Nocturia Product and Services
9.19.4 Rechon Life Science AB Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Rechon Life Science AB Recent Developments/Updates
9.19.6 Rechon Life Science AB Competitive Strengths & Weaknesses
9.20 Zhejiang Conba Pharmaceutical
9.20.1 Zhejiang Conba Pharmaceutical Details
9.20.2 Zhejiang Conba Pharmaceutical Major Business
9.20.3 Zhejiang Conba Pharmaceutical Nocturia Product and Services
9.20.4 Zhejiang Conba Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Zhejiang Conba Pharmaceutical Recent Developments/Updates
9.20.6 Zhejiang Conba Pharmaceutical Competitive Strengths & Weaknesses
9.21 Chengdu Leer Pharmaceutical
9.21.1 Chengdu Leer Pharmaceutical Details
9.21.2 Chengdu Leer Pharmaceutical Major Business
9.21.3 Chengdu Leer Pharmaceutical Nocturia Product and Services
9.21.4 Chengdu Leer Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Chengdu Leer Pharmaceutical Recent Developments/Updates
9.21.6 Chengdu Leer Pharmaceutical Competitive Strengths & Weaknesses
9.22 Nanjing Xingyin Pharmaceutical Group
9.22.1 Nanjing Xingyin Pharmaceutical Group Details
9.22.2 Nanjing Xingyin Pharmaceutical Group Major Business
9.22.3 Nanjing Xingyin Pharmaceutical Group Nocturia Product and Services
9.22.4 Nanjing Xingyin Pharmaceutical Group Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Nanjing Xingyin Pharmaceutical Group Recent Developments/Updates
9.22.6 Nanjing Xingyin Pharmaceutical Group Competitive Strengths & Weaknesses
9.23 Sun Pharmaceutical Industries Ltd.
9.23.1 Sun Pharmaceutical Industries Ltd. Details
9.23.2 Sun Pharmaceutical Industries Ltd. Major Business
9.23.3 Sun Pharmaceutical Industries Ltd. Nocturia Product and Services
9.23.4 Sun Pharmaceutical Industries Ltd. Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
9.23.6 Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
9.24 APOTEX INC
9.24.1 APOTEX INC Details
9.24.2 APOTEX INC Major Business
9.24.3 APOTEX INC Nocturia Product and Services
9.24.4 APOTEX INC Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 APOTEX INC Recent Developments/Updates
9.24.6 APOTEX INC Competitive Strengths & Weaknesses
9.25 Sagent Pharmaceuticals
9.25.1 Sagent Pharmaceuticals Details
9.25.2 Sagent Pharmaceuticals Major Business
9.25.3 Sagent Pharmaceuticals Nocturia Product and Services
9.25.4 Sagent Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Sagent Pharmaceuticals Recent Developments/Updates
9.25.6 Sagent Pharmaceuticals Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Nocturia Industry Chain
10.2 Nocturia Upstream Analysis
10.3 Nocturia Midstream Analysis
10.4 Nocturia Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF FIGURES
Table 1. World Nocturia Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Nocturia Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Nocturia Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Nocturia Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Nocturia Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Nocturia Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Nocturia Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Nocturia Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Nocturia Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Nocturia Players in 2025
Table 12. World Nocturia Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Nocturia Company Evaluation Quadrant
Table 14. Head Office of Key Nocturia Players
Table 15. Nocturia Market: Company Product Type Footprint
Table 16. Nocturia Market: Company Product Application Footprint
Table 17. Nocturia Mergers & Acquisitions Activity
Table 18. United States VS China Nocturia Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Nocturia Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Nocturia Companies, Headquarters (States, Country)
Table 21. United States Based Companies Nocturia Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Nocturia Revenue Market Share (2021-2026)
Table 23. China Based Nocturia Companies, Headquarters (Province, Country)
Table 24. China Based Companies Nocturia Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Nocturia Revenue Market Share (2021-2026)
Table 26. Rest of World Based Nocturia Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Nocturia Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Nocturia Revenue Market Share (2021-2026)
Table 29. World Nocturia Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Nocturia Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Nocturia Market Size by Type (2027-2032) & (USD Million)
Table 32. World Nocturia Market Size by Underlying Cause, (USD Million), 2021 & 2025 & 2032
Table 33. World Nocturia Market Size Value by Underlying Cause (2021-2026) & (USD Million)
Table 34. World Nocturia Market Size by Underlying Cause (2027-2032) & (USD Million)
Table 35. World Nocturia Market Size by Drug Category, (USD Million), 2021 & 2025 & 2032
Table 36. World Nocturia Market Size Value by Drug Category (2021-2026) & (USD Million)
Table 37. World Nocturia Market Size by Drug Category (2027-2032) & (USD Million)
Table 38. World Nocturia Market Size by Sale Channels, (USD Million), 2021 & 2025 & 2032
Table 39. World Nocturia Market Size by Sale Channels (2021-2026) & (USD Million)
Table 40. World Nocturia Market Size by Sale Channels (2027-2032) & (USD Million)
Table 41. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 42. Astellas Pharma Major Business
Table 43. Astellas Pharma Nocturia Product and Services
Table 44. Astellas Pharma Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Astellas Pharma Recent Developments/Updates
Table 46. Astellas Pharma Competitive Strengths & Weaknesses
Table 47. Allergan Basic Information, Manufacturing Base and Competitors
Table 48. Allergan Major Business
Table 49. Allergan Nocturia Product and Services
Table 50. Allergan Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Allergan Recent Developments/Updates
Table 52. Allergan Competitive Strengths & Weaknesses
Table 53. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Ferring Pharmaceuticals Major Business
Table 55. Ferring Pharmaceuticals Nocturia Product and Services
Table 56. Ferring Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Ferring Pharmaceuticals Recent Developments/Updates
Table 58. Ferring Pharmaceuticals Competitive Strengths & Weaknesses
Table 59. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 60. Eli Lilly Major Business
Table 61. Eli Lilly Nocturia Product and Services
Table 62. Eli Lilly Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Eli Lilly Recent Developments/Updates
Table 64. Eli Lilly Competitive Strengths & Weaknesses
Table 65. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 66. GlaxoSmithKline Major Business
Table 67. GlaxoSmithKline Nocturia Product and Services
Table 68. GlaxoSmithKline Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. GlaxoSmithKline Recent Developments/Updates
Table 70. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 71. Sanofi Basic Information, Manufacturing Base and Competitors
Table 72. Sanofi Major Business
Table 73. Sanofi Nocturia Product and Services
Table 74. Sanofi Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Sanofi Recent Developments/Updates
Table 76. Sanofi Competitive Strengths & Weaknesses
Table 77. Pfizer Basic Information, Manufacturing Base and Competitors
Table 78. Pfizer Major Business
Table 79. Pfizer Nocturia Product and Services
Table 80. Pfizer Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Pfizer Recent Developments/Updates
Table 82. Pfizer Competitive Strengths & Weaknesses
Table 83. Abbott Basic Information, Manufacturing Base and Competitors
Table 84. Abbott Major Business
Table 85. Abbott Nocturia Product and Services
Table 86. Abbott Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Abbott Recent Developments/Updates
Table 88. Abbott Competitive Strengths & Weaknesses
Table 89. Teva Basic Information, Manufacturing Base and Competitors
Table 90. Teva Major Business
Table 91. Teva Nocturia Product and Services
Table 92. Teva Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Teva Recent Developments/Updates
Table 94. Teva Competitive Strengths & Weaknesses
Table 95. Mylan Basic Information, Manufacturing Base and Competitors
Table 96. Mylan Major Business
Table 97. Mylan Nocturia Product and Services
Table 98. Mylan Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Mylan Recent Developments/Updates
Table 100. Mylan Competitive Strengths & Weaknesses
Table 101. Novartis Basic Information, Manufacturing Base and Competitors
Table 102. Novartis Major Business
Table 103. Novartis Nocturia Product and Services
Table 104. Novartis Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Novartis Recent Developments/Updates
Table 106. Novartis Competitive Strengths & Weaknesses
Table 107. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 108. Johnson & Johnson Major Business
Table 109. Johnson & Johnson Nocturia Product and Services
Table 110. Johnson & Johnson Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Johnson & Johnson Recent Developments/Updates
Table 112. Johnson & Johnson Competitive Strengths & Weaknesses
Table 113. Merck Basic Information, Manufacturing Base and Competitors
Table 114. Merck Major Business
Table 115. Merck Nocturia Product and Services
Table 116. Merck Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Merck Recent Developments/Updates
Table 118. Merck Competitive Strengths & Weaknesses
Table 119. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 120. Astra Zeneca Major Business
Table 121. Astra Zeneca Nocturia Product and Services
Table 122. Astra Zeneca Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Astra Zeneca Recent Developments/Updates
Table 124. Astra Zeneca Competitive Strengths & Weaknesses
Table 125. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 126. Bristol-Myers Squibb Major Business
Table 127. Bristol-Myers Squibb Nocturia Product and Services
Table 128. Bristol-Myers Squibb Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Bristol-Myers Squibb Recent Developments/Updates
Table 130. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 131. Hainan Zhonghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 132. Hainan Zhonghe Pharmaceutical Major Business
Table 133. Hainan Zhonghe Pharmaceutical Nocturia Product and Services
Table 134. Hainan Zhonghe Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Hainan Zhonghe Pharmaceutical Recent Developments/Updates
Table 136. Hainan Zhonghe Pharmaceutical Competitive Strengths & Weaknesses
Table 137. Fosun Pharma Basic Information, Manufacturing Base and Competitors
Table 138. Fosun Pharma Major Business
Table 139. Fosun Pharma Nocturia Product and Services
Table 140. Fosun Pharma Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Fosun Pharma Recent Developments/Updates
Table 142. Fosun Pharma Competitive Strengths & Weaknesses
Table 143. Hybio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 144. Hybio Pharmaceutical Major Business
Table 145. Hybio Pharmaceutical Nocturia Product and Services
Table 146. Hybio Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Hybio Pharmaceutical Recent Developments/Updates
Table 148. Hybio Pharmaceutical Competitive Strengths & Weaknesses
Table 149. Rechon Life Science AB Basic Information, Manufacturing Base and Competitors
Table 150. Rechon Life Science AB Major Business
Table 151. Rechon Life Science AB Nocturia Product and Services
Table 152. Rechon Life Science AB Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Rechon Life Science AB Recent Developments/Updates
Table 154. Rechon Life Science AB Competitive Strengths & Weaknesses
Table 155. Zhejiang Conba Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 156. Zhejiang Conba Pharmaceutical Major Business
Table 157. Zhejiang Conba Pharmaceutical Nocturia Product and Services
Table 158. Zhejiang Conba Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Zhejiang Conba Pharmaceutical Recent Developments/Updates
Table 160. Zhejiang Conba Pharmaceutical Competitive Strengths & Weaknesses
Table 161. Chengdu Leer Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 162. Chengdu Leer Pharmaceutical Major Business
Table 163. Chengdu Leer Pharmaceutical Nocturia Product and Services
Table 164. Chengdu Leer Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Chengdu Leer Pharmaceutical Recent Developments/Updates
Table 166. Chengdu Leer Pharmaceutical Competitive Strengths & Weaknesses
Table 167. Nanjing Xingyin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 168. Nanjing Xingyin Pharmaceutical Group Major Business
Table 169. Nanjing Xingyin Pharmaceutical Group Nocturia Product and Services
Table 170. Nanjing Xingyin Pharmaceutical Group Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Nanjing Xingyin Pharmaceutical Group Recent Developments/Updates
Table 172. Nanjing Xingyin Pharmaceutical Group Competitive Strengths & Weaknesses
Table 173. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 174. Sun Pharmaceutical Industries Ltd. Major Business
Table 175. Sun Pharmaceutical Industries Ltd. Nocturia Product and Services
Table 176. Sun Pharmaceutical Industries Ltd. Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 178. Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 179. APOTEX INC Basic Information, Manufacturing Base and Competitors
Table 180. APOTEX INC Major Business
Table 181. APOTEX INC Nocturia Product and Services
Table 182. APOTEX INC Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. APOTEX INC Recent Developments/Updates
Table 184. APOTEX INC Competitive Strengths & Weaknesses
Table 185. Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 186. Sagent Pharmaceuticals Major Business
Table 187. Sagent Pharmaceuticals Nocturia Product and Services
Table 188. Sagent Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Sagent Pharmaceuticals Recent Developments/Updates
Table 190. Sagent Pharmaceuticals Competitive Strengths & Weaknesses
Table 191. Global Key Players of Nocturia Upstream (Raw Materials)
Table 192. Global Nocturia Typical Customers
LIST OF FIGURES
Figure 1. Nocturia Picture
Figure 2. World Nocturia Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Nocturia Total Revenue (2021-2032) & (USD Million)
Figure 4. World Nocturia Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Nocturia Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Nocturia Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Nocturia Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Nocturia Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Nocturia Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Nocturia Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Nocturia Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Nocturia Revenue (2021-2032) & (USD Million)
Figure 13. Nocturia Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 16. World Nocturia Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 18. China Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 23. India Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Nocturia by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Nocturia Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Nocturia Markets in 2025
Figure 27. United States VS China: Nocturia Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Nocturia Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Nocturia Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Nocturia Market Size Market Share by Type in 2025
Figure 31. Desmopressin
Figure 32. Anticholinergic Drugs
Figure 33. Alpha Blockers
Figure 34. Diuretics
Figure 35. Others
Figure 36. World Nocturia Market Size Market Share by Type (2021-2032)
Figure 37. World Nocturia Market Size by Underlying Cause, (USD Million), 2021 & 2025 & 2032
Figure 38. World Nocturia Market Size Market Share by Underlying Cause in 2025
Figure 39. For Nocturnal Polyuria
Figure 40. For Overactive Bladder
Figure 41. For Prostate-related Nocturia
Figure 42. Others
Figure 43. World Nocturia Market Size Market Share by Underlying Cause (2021-2032)
Figure 44. World Nocturia Market Size by Drug Category, (USD Million), 2021 & 2025 & 2032
Figure 45. World Nocturia Market Size Market Share by Drug Category in 2025
Figure 46. Hormonal Drugs
Figure 47. Urological Functional Agents
Figure 48. BPH Symptom Therapies
Figure 49. Diuretics
Figure 50. Others
Figure 51. World Nocturia Market Size Market Share by Drug Category (2021-2032)
Figure 52. World Nocturia Market Size by Sale Channels, (USD Million), 2021 & 2025 & 2032
Figure 53. World Nocturia Market Size Market Share by Sale Channels in 2025
Figure 54. Hospital Pharmacies
Figure 55. Retail Pharmacies
Figure 56. Online Pharmacies
Figure 57. World Nocturia Market Size Market Share by Sale Channels (2021-2032)
Figure 58. Nocturia Industrial Chain
Figure 59. Methodology
Figure 60. Research Process and Data Source
Table 1. World Nocturia Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Nocturia Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Nocturia Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Nocturia Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Nocturia Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Nocturia Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Nocturia Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Nocturia Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Nocturia Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Nocturia Players in 2025
Table 12. World Nocturia Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Nocturia Company Evaluation Quadrant
Table 14. Head Office of Key Nocturia Players
Table 15. Nocturia Market: Company Product Type Footprint
Table 16. Nocturia Market: Company Product Application Footprint
Table 17. Nocturia Mergers & Acquisitions Activity
Table 18. United States VS China Nocturia Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Nocturia Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Nocturia Companies, Headquarters (States, Country)
Table 21. United States Based Companies Nocturia Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Nocturia Revenue Market Share (2021-2026)
Table 23. China Based Nocturia Companies, Headquarters (Province, Country)
Table 24. China Based Companies Nocturia Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Nocturia Revenue Market Share (2021-2026)
Table 26. Rest of World Based Nocturia Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Nocturia Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Nocturia Revenue Market Share (2021-2026)
Table 29. World Nocturia Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Nocturia Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Nocturia Market Size by Type (2027-2032) & (USD Million)
Table 32. World Nocturia Market Size by Underlying Cause, (USD Million), 2021 & 2025 & 2032
Table 33. World Nocturia Market Size Value by Underlying Cause (2021-2026) & (USD Million)
Table 34. World Nocturia Market Size by Underlying Cause (2027-2032) & (USD Million)
Table 35. World Nocturia Market Size by Drug Category, (USD Million), 2021 & 2025 & 2032
Table 36. World Nocturia Market Size Value by Drug Category (2021-2026) & (USD Million)
Table 37. World Nocturia Market Size by Drug Category (2027-2032) & (USD Million)
Table 38. World Nocturia Market Size by Sale Channels, (USD Million), 2021 & 2025 & 2032
Table 39. World Nocturia Market Size by Sale Channels (2021-2026) & (USD Million)
Table 40. World Nocturia Market Size by Sale Channels (2027-2032) & (USD Million)
Table 41. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 42. Astellas Pharma Major Business
Table 43. Astellas Pharma Nocturia Product and Services
Table 44. Astellas Pharma Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Astellas Pharma Recent Developments/Updates
Table 46. Astellas Pharma Competitive Strengths & Weaknesses
Table 47. Allergan Basic Information, Manufacturing Base and Competitors
Table 48. Allergan Major Business
Table 49. Allergan Nocturia Product and Services
Table 50. Allergan Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Allergan Recent Developments/Updates
Table 52. Allergan Competitive Strengths & Weaknesses
Table 53. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Ferring Pharmaceuticals Major Business
Table 55. Ferring Pharmaceuticals Nocturia Product and Services
Table 56. Ferring Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Ferring Pharmaceuticals Recent Developments/Updates
Table 58. Ferring Pharmaceuticals Competitive Strengths & Weaknesses
Table 59. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 60. Eli Lilly Major Business
Table 61. Eli Lilly Nocturia Product and Services
Table 62. Eli Lilly Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Eli Lilly Recent Developments/Updates
Table 64. Eli Lilly Competitive Strengths & Weaknesses
Table 65. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 66. GlaxoSmithKline Major Business
Table 67. GlaxoSmithKline Nocturia Product and Services
Table 68. GlaxoSmithKline Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. GlaxoSmithKline Recent Developments/Updates
Table 70. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 71. Sanofi Basic Information, Manufacturing Base and Competitors
Table 72. Sanofi Major Business
Table 73. Sanofi Nocturia Product and Services
Table 74. Sanofi Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Sanofi Recent Developments/Updates
Table 76. Sanofi Competitive Strengths & Weaknesses
Table 77. Pfizer Basic Information, Manufacturing Base and Competitors
Table 78. Pfizer Major Business
Table 79. Pfizer Nocturia Product and Services
Table 80. Pfizer Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Pfizer Recent Developments/Updates
Table 82. Pfizer Competitive Strengths & Weaknesses
Table 83. Abbott Basic Information, Manufacturing Base and Competitors
Table 84. Abbott Major Business
Table 85. Abbott Nocturia Product and Services
Table 86. Abbott Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Abbott Recent Developments/Updates
Table 88. Abbott Competitive Strengths & Weaknesses
Table 89. Teva Basic Information, Manufacturing Base and Competitors
Table 90. Teva Major Business
Table 91. Teva Nocturia Product and Services
Table 92. Teva Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Teva Recent Developments/Updates
Table 94. Teva Competitive Strengths & Weaknesses
Table 95. Mylan Basic Information, Manufacturing Base and Competitors
Table 96. Mylan Major Business
Table 97. Mylan Nocturia Product and Services
Table 98. Mylan Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Mylan Recent Developments/Updates
Table 100. Mylan Competitive Strengths & Weaknesses
Table 101. Novartis Basic Information, Manufacturing Base and Competitors
Table 102. Novartis Major Business
Table 103. Novartis Nocturia Product and Services
Table 104. Novartis Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Novartis Recent Developments/Updates
Table 106. Novartis Competitive Strengths & Weaknesses
Table 107. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 108. Johnson & Johnson Major Business
Table 109. Johnson & Johnson Nocturia Product and Services
Table 110. Johnson & Johnson Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Johnson & Johnson Recent Developments/Updates
Table 112. Johnson & Johnson Competitive Strengths & Weaknesses
Table 113. Merck Basic Information, Manufacturing Base and Competitors
Table 114. Merck Major Business
Table 115. Merck Nocturia Product and Services
Table 116. Merck Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Merck Recent Developments/Updates
Table 118. Merck Competitive Strengths & Weaknesses
Table 119. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 120. Astra Zeneca Major Business
Table 121. Astra Zeneca Nocturia Product and Services
Table 122. Astra Zeneca Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Astra Zeneca Recent Developments/Updates
Table 124. Astra Zeneca Competitive Strengths & Weaknesses
Table 125. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 126. Bristol-Myers Squibb Major Business
Table 127. Bristol-Myers Squibb Nocturia Product and Services
Table 128. Bristol-Myers Squibb Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Bristol-Myers Squibb Recent Developments/Updates
Table 130. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 131. Hainan Zhonghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 132. Hainan Zhonghe Pharmaceutical Major Business
Table 133. Hainan Zhonghe Pharmaceutical Nocturia Product and Services
Table 134. Hainan Zhonghe Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Hainan Zhonghe Pharmaceutical Recent Developments/Updates
Table 136. Hainan Zhonghe Pharmaceutical Competitive Strengths & Weaknesses
Table 137. Fosun Pharma Basic Information, Manufacturing Base and Competitors
Table 138. Fosun Pharma Major Business
Table 139. Fosun Pharma Nocturia Product and Services
Table 140. Fosun Pharma Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Fosun Pharma Recent Developments/Updates
Table 142. Fosun Pharma Competitive Strengths & Weaknesses
Table 143. Hybio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 144. Hybio Pharmaceutical Major Business
Table 145. Hybio Pharmaceutical Nocturia Product and Services
Table 146. Hybio Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Hybio Pharmaceutical Recent Developments/Updates
Table 148. Hybio Pharmaceutical Competitive Strengths & Weaknesses
Table 149. Rechon Life Science AB Basic Information, Manufacturing Base and Competitors
Table 150. Rechon Life Science AB Major Business
Table 151. Rechon Life Science AB Nocturia Product and Services
Table 152. Rechon Life Science AB Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Rechon Life Science AB Recent Developments/Updates
Table 154. Rechon Life Science AB Competitive Strengths & Weaknesses
Table 155. Zhejiang Conba Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 156. Zhejiang Conba Pharmaceutical Major Business
Table 157. Zhejiang Conba Pharmaceutical Nocturia Product and Services
Table 158. Zhejiang Conba Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Zhejiang Conba Pharmaceutical Recent Developments/Updates
Table 160. Zhejiang Conba Pharmaceutical Competitive Strengths & Weaknesses
Table 161. Chengdu Leer Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 162. Chengdu Leer Pharmaceutical Major Business
Table 163. Chengdu Leer Pharmaceutical Nocturia Product and Services
Table 164. Chengdu Leer Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Chengdu Leer Pharmaceutical Recent Developments/Updates
Table 166. Chengdu Leer Pharmaceutical Competitive Strengths & Weaknesses
Table 167. Nanjing Xingyin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 168. Nanjing Xingyin Pharmaceutical Group Major Business
Table 169. Nanjing Xingyin Pharmaceutical Group Nocturia Product and Services
Table 170. Nanjing Xingyin Pharmaceutical Group Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Nanjing Xingyin Pharmaceutical Group Recent Developments/Updates
Table 172. Nanjing Xingyin Pharmaceutical Group Competitive Strengths & Weaknesses
Table 173. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 174. Sun Pharmaceutical Industries Ltd. Major Business
Table 175. Sun Pharmaceutical Industries Ltd. Nocturia Product and Services
Table 176. Sun Pharmaceutical Industries Ltd. Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 178. Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 179. APOTEX INC Basic Information, Manufacturing Base and Competitors
Table 180. APOTEX INC Major Business
Table 181. APOTEX INC Nocturia Product and Services
Table 182. APOTEX INC Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. APOTEX INC Recent Developments/Updates
Table 184. APOTEX INC Competitive Strengths & Weaknesses
Table 185. Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 186. Sagent Pharmaceuticals Major Business
Table 187. Sagent Pharmaceuticals Nocturia Product and Services
Table 188. Sagent Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Sagent Pharmaceuticals Recent Developments/Updates
Table 190. Sagent Pharmaceuticals Competitive Strengths & Weaknesses
Table 191. Global Key Players of Nocturia Upstream (Raw Materials)
Table 192. Global Nocturia Typical Customers
LIST OF FIGURES
Figure 1. Nocturia Picture
Figure 2. World Nocturia Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Nocturia Total Revenue (2021-2032) & (USD Million)
Figure 4. World Nocturia Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Nocturia Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Nocturia Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Nocturia Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Nocturia Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Nocturia Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Nocturia Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Nocturia Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Nocturia Revenue (2021-2032) & (USD Million)
Figure 13. Nocturia Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 16. World Nocturia Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 18. China Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 23. India Nocturia Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Nocturia by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Nocturia Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Nocturia Markets in 2025
Figure 27. United States VS China: Nocturia Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Nocturia Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Nocturia Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Nocturia Market Size Market Share by Type in 2025
Figure 31. Desmopressin
Figure 32. Anticholinergic Drugs
Figure 33. Alpha Blockers
Figure 34. Diuretics
Figure 35. Others
Figure 36. World Nocturia Market Size Market Share by Type (2021-2032)
Figure 37. World Nocturia Market Size by Underlying Cause, (USD Million), 2021 & 2025 & 2032
Figure 38. World Nocturia Market Size Market Share by Underlying Cause in 2025
Figure 39. For Nocturnal Polyuria
Figure 40. For Overactive Bladder
Figure 41. For Prostate-related Nocturia
Figure 42. Others
Figure 43. World Nocturia Market Size Market Share by Underlying Cause (2021-2032)
Figure 44. World Nocturia Market Size by Drug Category, (USD Million), 2021 & 2025 & 2032
Figure 45. World Nocturia Market Size Market Share by Drug Category in 2025
Figure 46. Hormonal Drugs
Figure 47. Urological Functional Agents
Figure 48. BPH Symptom Therapies
Figure 49. Diuretics
Figure 50. Others
Figure 51. World Nocturia Market Size Market Share by Drug Category (2021-2032)
Figure 52. World Nocturia Market Size by Sale Channels, (USD Million), 2021 & 2025 & 2032
Figure 53. World Nocturia Market Size Market Share by Sale Channels in 2025
Figure 54. Hospital Pharmacies
Figure 55. Retail Pharmacies
Figure 56. Online Pharmacies
Figure 57. World Nocturia Market Size Market Share by Sale Channels (2021-2032)
Figure 58. Nocturia Industrial Chain
Figure 59. Methodology
Figure 60. Research Process and Data Source
